PharmaShots | Incisive News in 3 Shots

Subscribe Now

Roche

Roche received the EU’s CHMP Positive Opinion for subcutaneous injection of Tecentriq to treat multiple types of cancer

Roche received the EU’s CHMP Positive Opinion for subcutaneous injection of Tecentriq to treat multiple types of cancer

November 14, 2023

Roche Reports the Results of Elevidys in P-III Trial for the Treatment of Duchenne Muscular Dystrophy (DMD)

Roche Reports the Results of Elevidys in P-III Trial for the Treatment of Duchenne Muscular Dystrophy (DMD)

October 31, 2023

Roche Reports the Acquisition of Telavant along with its Asset RVT-3101 from Roivant for the Treatment of Inflammatory Bowel Disease

Roche Reports the Acquisition of Telavant along with its Asset RVT-3101 from Roivant for the Treatment of Inflammatory Bowel Disea...

October 23, 2023

Roche’s Glofitamab Receives NICE Recommendation for the Treatment of Diffuse Large B-Cell Lymphoma

Roche’s Glofitamab Receives NICE Recommendation for the Treatment of Diffuse Large B-Cell Lymphoma

October 19, 2023

PharmaShots Weekly Snapshots (October 09–13, 2023) _

PharmaShots Weekly Snapshots (October 09–13, 2023) _

October 14, 2023

Roche Reports P-III Studies (BALATON) & (COMINO) Results of Vabysmo (faricimab) for the Treatment of Retinal Vein Occlusion

Roche Reports P-III Studies (BALATON) & (COMINO) Results of Vabysmo (faricimab) for the Treatment of Retinal Vein Occlusion

October 11, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us